Scinai Immunotherapeutics (SCNI) Retained Earnings (2015 - 2026)
Scinai Immunotherapeutics (SCNI) reported Retained Earnings of -$122.3 million for Q1 2026, up 2.84% sequentially from -$125.8 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Retained Earnings (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 12 years of Retained Earnings data on file, last reported at -$122.3 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings changed N/A year-over-year to -$122.3 million; the trailing twelve-month figure through Mar 2026 stood at -$122.3 million (changed N/A YoY), and the FY2025 full-year result was -$125.8 million, down 201.79% from the prior year.
- Retained Earnings climbed to -$122.3 million in Q1 2026, from -$125.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $123.6 million in Q4 2024 to a low of -$126.8 million in Q2 2024.
- A 5-year average of -$79.6 million and a median of -$117.8 million in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 5536.74% in 2022 and soared 7205.11% in 2024, its largest moves.
- Tracing SCNI's Retained Earnings over 5 years: stood at -$115.8 million in 2022, then jumped by 98.5% to -$1.7 million in 2023, then soared by 7205.11% to $123.6 million in 2024, then slumped by 201.79% to -$125.8 million in 2025, then advanced by 2.84% to -$122.3 million in 2026.
- Business Quant data shows SCNI's Retained Earnings at -$122.3 million in Q1 2026, -$125.8 million in Q4 2025, and -$121.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -122.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.27 Mn |
| Dec 31, 2025 | -125.85 Mn |
| Jun 30, 2025 | -121.67 Mn |
| Dec 31, 2024 | 123.63 Mn |
| Sep 30, 2024 | -115.31 Mn |
| Jun 30, 2024 | -126.82 Mn |
| Mar 31, 2024 | -124.49 Mn |
| Dec 31, 2023 | -1.74 Mn |
| Sep 30, 2023 | -120.01 Mn |
| Jun 30, 2023 | -123.11 Mn |
| Mar 31, 2023 | 116.43 Mn |
| Dec 31, 2022 | -115.84 Mn |
| Sep 30, 2022 | -108.18 Mn |
| Jun 30, 2022 | -110.58 Mn |
| Mar 31, 2022 | -117.82 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Sep 30, 2021 | -109.64 Mn |
| Jun 30, 2021 | -344.97 Bn |
| Mar 31, 2021 | -332.98 Bn |
| Dec 31, 2020 | -324.79 Bn |